[ Pharmaceutical preparations produced using biomaterials via biotechnological processes for the treatment of cancer, autoimmune diseases, cardiovascular disease, inflammatory diseases, macular degeneration, transplant rejection, multiple sclerosis, and viral infections; biotechnological preparations for medical use, namely, monoclonal antibodies for the treatment of cancer, autoimmune diseases, cardiovascular disease, inflammatory diseases, macular degeneration, transplant rejection, multipl...